Compugen reported $1.84M in Interest Income for its fiscal quarter ending in June of 2026.





Interest Income Change Date
Arca Biopharma USD 4.09M 441K Mar/2025
aTyr Pharma USD 8.86K 2.33K Jun/2026
Bio Path USD 4K 0 Dec/2024
Cara Therapeutics USD 347K 74K Mar/2025
Compugen USD 1.84M 699K Jun/2026
Immunic USD -0.24 0.03 Sep/2024
RedHill Biopharma USD 7.1M 14.49M Jun/2023